Marianne Davies on Immunotherapy-Related Side Effects in Lung Cancer

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

Related Videos

Related Content

Advertisement

May 7th 2025

Breaking Barriers: Why Increasing Lung Screening is Critical

Lung Cancer Initiative (LCI)

Lung cancer remains the leading cause of cancer-related deaths in the U.S.

March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.

February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

May 7th 2025

How Quitting Smoking After a Cancer Diagnosis Can Boost Survival

Ryan Scott

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

May 6th 2025

First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

Spencer Feldman

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.

Related Content

Advertisement

May 7th 2025

Breaking Barriers: Why Increasing Lung Screening is Critical

Lung Cancer Initiative (LCI)

Lung cancer remains the leading cause of cancer-related deaths in the U.S.

March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.

February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

May 7th 2025

How Quitting Smoking After a Cancer Diagnosis Can Boost Survival

Ryan Scott

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

May 6th 2025

First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

Spencer Feldman

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.